For Investors For Entrepreneurs

Two week extension to Fertility Focus and OvuSense campaign

Shadow Foundr’s investment campaign for Fertility Focus has been extended until Monday 16th July. The company’s revolutionary, patented product, Ovusense, which doubles the chances of conception each month, continues to enjoy record sales during the first half of 2018.

LIfT BioSciences Wins BioVaria 2018

Shadow Foundr is delighted to announce that one of the companies it has raised for, LIfT BioSciences, has been awarded Best Rising Start-Up at BioVaria 2018 by an experienced panel of judges, comprising major Pharma Companies, Venture Capital Firms & NGOs.

Read More